Top Story

Prasugrel fails to ease vaso-occlusion burden in sickle cell disease

May 24, 2016

Treatment with prasugrel did not significantly reduce the rate of vaso-occlusive crisis in children and adolescents with sickle cell anemia, according to the results of a phase 3 trial.

Safety outcomes appeared similar among children and adolescents assigned prasugrel (Effient; Daiichi Sankyo, Eli Lilly) and those assigned placebo, results showed.

Meeting News CoveragePerspective

Granisetron patch prevents CINV for patients with hematologic malignancies

May 24, 2016
Granisetron transdermal system patch prevented chemotherapy-induced nausea…
In the Journals

Overweight patients less likely to die of colorectal cancer

May 24, 2016
BMI at the time of colorectal cancer diagnosis is associated with mortality risk, according to results of a retrospective observational study.Patients categorized as…
In the Journals

Geriatric events increase morbidity, costs among older patients who undergo cancer surgery

May 24, 2016
Older individuals who underwent cancer surgery appeared likely to experience geriatric events, such as falls and fractures, delirium and dehydration.These events —…
Meeting News Coverage

Top Takeaways from ASH: Oral anticoagulants shift cancer-related thrombosis treatment paradigm

May 24, 2016
With a range of questions lingering unanswered in the arena of cancer-related thrombosis, new research presented at the ASH Annual Meeting and Exposition armed…
More News Headlines »

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small…
More »
At Issue

VIDEO: Emerging data on checkpoint blockades suggest potential ‘cure’ for certain tumors, not all cancer

May 16, 2016
More »
AACR Annual Meeting

AACR Annual Meeting

CME Video

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Current Issues
View the Current Issue
HemOnc Today